Zhao, R.; Liu, J.; Li, Z.; Zhang, W.; Wang, F.; Zhang, B.
Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 2022, 14, 1541.
https://doi.org/10.3390/pharmaceutics14081541
AMA Style
Zhao R, Liu J, Li Z, Zhang W, Wang F, Zhang B.
Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics. 2022; 14(8):1541.
https://doi.org/10.3390/pharmaceutics14081541
Chicago/Turabian Style
Zhao, Ruogang, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang, and Bo Zhang.
2022. "Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy" Pharmaceutics 14, no. 8: 1541.
https://doi.org/10.3390/pharmaceutics14081541
APA Style
Zhao, R., Liu, J., Li, Z., Zhang, W., Wang, F., & Zhang, B.
(2022). Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics, 14(8), 1541.
https://doi.org/10.3390/pharmaceutics14081541